Tag: biosimilars 2025
Blockbuster Patent Expirations 2025 and Beyond: Key Drugs, Timeline, and Market Impact
In 2025 and beyond, dozens of top-selling drugs like Entresto, Eliquis, and Keytruda lose patent protection, triggering massive price drops and biosimilar competition. Here's the full timeline and what it means for patients, pharmacies, and drugmakers.
